The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Survival benefit to immunotherapy according to site of organ involvement in metastatic anal cancer.
 
Arjun S Peddireddy
No Relationships to Disclose
 
Benny Johnson
Consulting or Advisory Role - Gritstone Bio; Incyte; Insmed; Pfizer; Taiho Oncology
Research Funding - Bristol-Myers Squibb (Inst); Gateway Foundation (Inst); Syntrix Biosystems (Inst)
 
Robert A. Wolff
Honoraria - Conveners; Emirates Oncology Society; Modern Medicine
Patents, Royalties, Other Intellectual Property - Royalties from McGraw-Hill: Editor: M.D. Anderson Manual of Medical Oncology, 3rd edition.
 
Ryan Huey
Honoraria - Bayer; Intellisphere, LLC
 
Emma Holliday
Research Funding - Merck Serono
 
Prajnan Das
Honoraria - Bayer; Imedex; Physicans' Education Resource
 
John Michael Skibber
No Relationships to Disclose
 
Shaelynn Portier
No Relationships to Disclose
 
Wai Chin Foo
No Relationships to Disclose
 
Daniel M. Halperin
Consulting or Advisory Role - Advanced Accelerator Applications; Camurus; Chimeric Therapeutics; Crinetics Pharmaceuticals; Curium Pharma; Ipsen; Isotopen Technologien; Lexicon; Novartis; Progenics; Radiomedix; Tersera
Research Funding - Advanced Accelerator Applications (Inst); Genentech/Roche (Inst); Isotopen Technologien (Inst); Tarveda Therapeutics (Inst); Thermo Fisher Scientific (Inst)
 
Van K. Morris
Consulting or Advisory Role - Axiom Healthcare Strategies; Bicara Therapeutics; BioMedical Insights; Boehringer Ingelheim; Incyte
Research Funding - Bicara Therapeutics (Inst); BioNTech (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Immatics; Pfizer (Inst)